Commission Decision of 12 June 2007 allowing Member States to extend provisional authorisations granted for the new active substance novaluron (notified under document number C(2007) 2454) (Text with EEA relevance) (2007/404/EC) (repealed) in Scotland

EU Decision 2007/404 · Adopted 12 June 2007 · Extends to United Kingdom

Commission Decision

of 12 June 2007

allowing Member States to extend provisional authorisations granted for the new active substance novaluron

(notified under document number C(2007) 2454)

(Text with EEA relevance)

(2007/404/EC) (repealed)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations to the whole text

F1: Repealed by 2009/579/EC: Commission Decision of 29 July 2009 allowing Member States to extend provisional authorisations granted for the new active substances acequinocyl, aminopyralid, ascorbic acid, benalaxyl-M, mandipropamid, novaluron, proquinazid, spirodiclofen and spiromesifen (notified under document number C(2009) 5582) (Text with EEA relevance).

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .